Yahoo
NasdaqCM - BOATS Real Time Price USD

Psyence Biomedical Ltd. (PBM)

4.4700 +0.8600 (+23.82%)
At close: August 18 at 4:00:01 PM EDT
4.3300 -0.1400 (-3.13%)
Overnight: 3:19:33 AM EDT
Chart Range Bar
Loading chart for PBM
Chart does not reflect overnight price.
  • Previous Close 3.6100
  • Open 3.6000
  • Bid 3.5300 x 200
  • Ask 5.2000 x 200
  • Day's Range 3.5200 - 5.0000
  • 52 Week Range 1.9200 - 216.4062
  • Volume 851,146
  • Avg. Volume 88,842
  • Market Cap (intraday) 17.05M
  • Beta (5Y Monthly) 1.67
  • PE Ratio (TTM) --
  • EPS (TTM) -15.4200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.

psyencebiomed.com

12

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 8/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PBM
84.80%
S&P 500 (^GSPC)
12.36%

1-Year Return

PBM
96.53%
S&P 500 (^GSPC)
19.27%

3-Year Return

PBM
100.00%
S&P 500 (^GSPC)
76.02%

5-Year Return

PBM
100.00%
S&P 500 (^GSPC)
74.80%

Statistics

View More

Valuation Measures

Annual
As of 8/17/2026
  • Market Cap

    13.77M

  • Enterprise Value

    14.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.82

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -31.33%

  • Return on Equity (ttm)

    -58.62%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -6.94M

  • Diluted EPS (ttm)

    -15.4200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.44M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.96M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.4700 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: